Markets:

Overview

News

Currencies

International

Treasuries

Alpha Cognition Inc. - Common Stock (NQ:ACOG)

5.080 -0.260 (-4.87%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alpha Cognition Inc. - Common Stock

< Previous 1 2 Next >

Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q4 Revenue Miss Amid Strong Alzheimer's Drug Launch ↗

March 26, 2026

Via Chartmill

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

March 26, 2026

From Alpha Cognition Inc.

Via Business Wire

Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗

March 15, 2026

This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.

Via The Motley Fool

Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗

March 15, 2026

Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.

Via The Motley Fool

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

October 15, 2025

Via TheNewswire.com

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

March 13, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences

March 10, 2026

From Alpha Cognition Inc.

Via Business Wire

Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗

March 05, 2026

This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries.

Via The Motley Fool

Topics Artificial Intelligence

Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study

February 25, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

February 18, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

January 07, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

December 01, 2025

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025

November 14, 2025

Dallas, Texas--(Newsfile Corp. - November 14, 2025) - Alpha...

Via Newsfile

Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q3 2025 Revenue Beat and Strong Commercial Progress for ZUNVEYL ↗

November 13, 2025

Alpha Cognition's Q3 2025 results beat revenue estimates by 37% on strong sales of its Alzheimer's drug, ZUNVEYL, showing significant commercial momentum.

Via Chartmill

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

November 13, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

October 30, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

October 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings

October 14, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Present Clinical Data at ASCP Annual Meeting

October 06, 2025

From Alpha Cognition Inc.

Via Business Wire

BioMedNewsBreaks — Alpha Cognition Inc. (NASDAQ: ACOG) Prices $35 Million Oversubscribed Public Offering

October 03, 2025

Via Investor Brand Network

Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares

September 30, 2025

From Alpha Cognition Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares

September 30, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

August 28, 2025

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025

August 15, 2025

Dallas, Texas--(Newsfile Corp. - August 15, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate...

Via Newsfile

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 14, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

August 04, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease

July 29, 2025

From Alpha Cognition Inc.

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.